CTX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Jan 2025)
What this means for you
Registered since 18 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87878032
- Registration number
- 5778925
- Mark type
- Stylized text
- Filed
- 16 Apr 2018
- Published for opposition
- 02 Apr 2019
- Registered
- 18 Jun 2019
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceuticals for the treatment of attention deficit/hyperactivity disorder (ADHD); conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention- deficit/hyperactivity disorder (ADHD)
Owner
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
Prosecution history
- 01 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Aug 2024 — TEAS SECTION 8 & 15 RECEIVED
- 18 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 02 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2019 — PUBLISHED FOR OPPOSITION
- 13 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Feb 2019 — ASSIGNED TO LIE
- 06 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jan 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED